This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmaceutical companies spend a huge amount of time and resources on creating valuable brand strategies, but when they come to life there’s often a disconnect. Strategy and execution can easily drift apart when tactics come to life, making it harder for them to drive business and deliver on the long-term action plans to engage with healthcare professionals.
Michael Ratcliffe brings both deep industry expertise and intelligence and strategy consulting capabilities to the firm. Boston, Mass. November 26, 2019 — Fuld + Company, a global competitive strategy consultancy, today announced the recent appointment of Michael Ratcliffe as a Senior Director and Head of the Health & Life Sciences Practice.
What is the difference between the pharma sector and other sectors? Experts rate the pharma sector quite higher than others because of its huge potential for growth. Because of the tremendous progress in the Indian economy, every pharma company can expect good earnings. However, it is also essential to know about the ways of expanding and popularizing the business.
Will Soliman, Chairman and CEO, of Accreditation Council for Medical Affairs (ACMA) discusses the exciting opportunities available to pharmacists in the pharma industry and how to pursue them. Name: William Soliman. Title: Chairman, Accreditation Council for Medical Affairs (ACMA). Program: Board Certified Medical Affairs Specialist (BCMAS). Interview Summary.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
As a pharmacist, helping people is part of your job. For many, it’s why you decided to join the healthcare field, and what drives you—making sure your patients are happy and healthy. You’re already working to make the world a better place and giving back to the community on a daily basis. But, during the holiday season, it’s even more important to help those in need. 9 ideas for giving back to the community The season of gifts and good cheer is hard for people who are struggling—financially, em
I have seen the prescribing cascade happen in clinical practice far too many times! One of those classic examples is heart failure. A patient is placed on a new medication that contributes to edema and heart failure. With a period of days to weeks, that patient is then placed on diuretics or doses have had […]. The post Top 5 Medications to Avoid In Heart Failure appeared first on Med Ed 101.
If you don’t have it yourself, you probably know at least one person living with diabetes. More than 37 million people in the U.S. alone have the condition. Whether you take prescription medications or not, you’re likely familiar with the hassle of having to monitor your blood glucose levels at all times. The process involves pricking your finger tip with a needle to test a drop of blood—ouch!
If you don’t have it yourself, you probably know at least one person living with diabetes. More than 37 million people in the U.S. alone have the condition. Whether you take prescription medications or not, you’re likely familiar with the hassle of having to monitor your blood glucose levels at all times. The process involves pricking your finger tip with a needle to test a drop of blood—ouch!
I’ve written thousands of recommendations to physicians and other healthcare providers throughout my career. I’ve gotten over the fear of failure so to speak, but there’s always still a little doubt in the back of my mind when a physician doesn’t do what I’m recommending. Here are some strategies I employ to help combat this […].
I’m working on a new book that I’m super excited about! I’m writing a book on drug interactions and hope to finish by the end of the year! I’m tackling the top 200 drugs plus those I consider very clinically relevant in practice. My hope is that it is a perfect resource for ambulatory care, […]. The post Carbamazepine Interactions – What to do About Them?
Insomnia is a sneaky condition that can lead to polypharmacy. Many of the medications used in the management of insomnia can work for a short period of time, but I’ve seen so many cases where the effects wear off over time. Always remember to do our due diligence on non-pharmacologic interventions! Here’s a case scenario […]. The post Insomnia Polypharmacy appeared first on Med Ed 101.
I’m saddened for some of my friends and colleagues who’ve recently lost their job. The recent move by HealthPartners in my own state hits close to home. HealthPartners is closing up 30 retail pharmacies and this means further tightening of the saturated job market. If you are looking at the traditional pharmacy workforce, the 2020 […].
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Metformin is the go-to first-line medication in type 2 diabetes. While drug interactions aren’t incredibly common with its use, we should be aware of OCT inhibition and the potential effects that this might cause. Under normal circumstances, this isn’t necessarily a drug interaction that will be life-threatening, but one that could have some mild to […].
In the case scenario below, I discuss the implications of the verapamil phenytoin interaction. JS is a 38-year-old male who has been on phenytoin for seizure prophylaxis for several years. He reports to his primary care provider complaining of severe headaches. He is diagnosed with cluster headaches. Over the next year, he continues to have […].
KS is a 79-year-old female. She states that she takes too many pills and would like to try to reduce some. Here’s her list. Aspirin 81 mg daily Clopidogrel 75 mg daily Pantoprazole 40 mg daily Valsartan 80 mg daily Metoprolol 25 mg BID Amlodipine 5 mg daily Mirtazapine 15 mg at bedtime Famotidine 20 […]. The post Case Scenario: Polypharmacy List Review appeared first on Med Ed 101.
40
40
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content